Goldman Sachs Downgrades DENTSPLY International (XRAY) to Neutral

Goldman Sachs downgraded DENTSPLY International (NASDAQ: XRAY) from Buy to Neutral with a price target of $49.00 (from $55.00).

Analyst Robert P. Jones said, "We think upside is limited by XRAY’s 45% exposures to Europe and more modest internal US growth. We lower 2015 EPS to $2.65 from $2.78 (-3% below Street at $2.74), though valuation provides downside support with the stock trading 10% below its historical premium to the S&P. Since we added XRAY to the Buy List (12/11/13) it is -6.6% vs. S&P/Dental 5.9%/-0.4%."

For an analyst ratings summary and ratings history on DENTSPLY International click here. For more ratings news on DENTSPLY International click here.

Shares of DENTSPLY International closed at $45.30 yesterday.

You May Also Be Interested In

• BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
• CrowdStrike (CRWD) PT Raised to $235 at TD Cowen
• Palo Alto Networks (PANW) PT Raised to $475 at Wells Fargo